SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-075997
Filing Date
2023-06-29
Accepted
2023-06-29 06:03:54
Documents
13
Period of Report
2023-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2319838d1_8k.htm   iXBRL 8-K 40377
2 EXHIBIT 10.1 tm2319838d1_ex10-1.htm EX-10.1 75714
  Complete submission text file 0001104659-23-075997.txt   310156

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA clrb-20230623.xsd EX-101.SCH 3224
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE clrb-20230623_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clrb-20230623_pre.xml EX-101.PRE 22357
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2319838d1_8k_htm.xml XML 3495
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 231054142
SIC: 2834 Pharmaceutical Preparations